46.46.Z - Wholesale trade of pharmaceutical and medical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
26.51.Z - Manufacture of measuring, controlling, and navigation instruments
32.50.Z - Production of medical devices, instruments, and products, including dental products
33.13.Z - Repair and maintenance of electronic and optical devices
33.20.Z - Installation of industrial machinery, equipment, and devices
70.10.Z - Head office activities
72.11.Z - Scientific research and development activities
77 - Rental and leasing
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,6 | -2,9 | -0,8 | 71 |
EBITDA | -0,3 | -0,6 | -0,7 | -25,7 |
Short time liabilities | 0,6 | 0,2 | 0 | -83,3 |
Equity capital | 3,9 | 4,3 | 3,5 | -19,5 |
Operating profit (EBIT) | -0,3 | -0,6 | -0,7 | -32,3 |
Assets | 4,5 | 4,5 | 3,4 | -26 |
Net profit (loss) | -0,6 | -2,9 | -0,8 | 71 |
Cash | 0,3 | 2,3 | 0,6 | -72 |
Net income from sale | 2,5 | 1,1 | 0,3 | -74,7 |
Liabilities and provisions for liabilities | 0,6 | 0,2 | 0 | -83,3 |
Working assets | 4,5 | 4,5 | 3,4 | -26 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -14 | -67,3 | -24,2 | 43,1 |
Equity capital to total assets | 86,6 | 95,4 | 99 | 3,6 |
Gross profit margin | -21,9 | -271,3 | -310,6 | -39,3 |
EBITDA Margin | -13,7 | -51,3 | -254,7 | -203,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 88 | 71 | 47 | -24 |
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane